Cargando…
Inhibitory role of ATF3 in gastric cancer progression through regulating cell EMT and stemness
BACKGROUND: Gastric cancer (GC) is one of the most common cancers and the third leading cause of cancer related mortality worldwide. The 5-year survival rate is rather low owing to advanced unresectable and distant metastasis. The EMT has been widely implicated in the stemness, metastatic dormancy,...
Autores principales: | Huang, Chuanqian, Chen, Renli, Zheng, Fangjing, Tang, Yirong, Wang, Xiukang, Chen, Zichun, Lai, Xiaolan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893881/ https://www.ncbi.nlm.nih.gov/pubmed/33608016 http://dx.doi.org/10.1186/s12935-021-01828-9 |
Ejemplares similares
-
Bortezomib Inhibits Multiple Myeloma Cells by Transactivating ATF3 to Trigger miR-135a-5p- Dependent Apoptosis
por: Lai, Xiaolan, et al.
Publicado: (2021) -
As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through the EMT pathway
por: Ma, Shuo, et al.
Publicado: (2021) -
The interplay between ATF2 and NEAT1 contributes to lung adenocarcinoma progression
por: Liu, Jian, et al.
Publicado: (2020) -
CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway
por: Yuan, Wanqiong, et al.
Publicado: (2021) -
CCNI2 promotes the progression of human gastric cancer through HDGF
por: Chen, Wenchao, et al.
Publicado: (2021)